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Background-—Chronic infections have been reported to be risk factors for both coronary heart disease and ischemic stroke. DNA
of oral bacteria, mainly from the viridans streptococci group, has been detected in coronary thrombus aspirates of myocardial
infarction and cerebral aneurysms. Viridans streptococci are known to cause infective endocarditis and possess thrombogenic
properties. We studied the presence of oral bacterial DNA in thrombus aspirates of patients with acute ischemic stroke treated
with mechanical thrombectomy.
Methods and Results-—Thrombus aspirates and arterial blood were taken from 75 patients (69% men; mean age, 67 years) with
acute ischemic stroke. The presence of Streptococcus species, mainly the Streptococcus mitis group, belonging to viridans
streptococci as well as Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans in samples were determined using a
quantitative polymerase chain reaction with speciﬁc primers and probes. The relative amount of bacterial DNA in a sample was
determined with the comparative threshold cycle method. Bacterial DNA was detected in 84% (n=63) of aspired thrombi, and 16%
(n=12) of samples were considered bacterial DNA negative. DNA of Streptococcus species, mainly the S mitis group, was found in
79% (n=59) of samples. The median relative amount of Streptococcus species DNA was 5.10-fold higher compared with the control
blood samples from the same patients. All thrombi were negative for both P gingivalis and A actinomycetemcomitans.
Conclusions-—This is the ﬁrst study showing the common presence of bacterial DNA from viridans streptococci in aspired thrombi
of patients with acute ischemic stroke. Streptococcal bacteria, mostly of oral origin, may contribute to the progression and
thrombotic events of cerebrovascular diseases. ( J Am Heart Assoc. 2019;8:e012330. DOI: 10.1161/JAHA.119.012330.)
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C ardiovascular and cerebrovascular diseases are majorcauses of death, and stroke is the leading cause of
adult long-term disability in western countries.1 Stroke can
be divided into intracerebral hemorrhage, subarachnoid
hemorrhage, and cerebral ischemia. In the Unites States of
America, 795 000 people experience stroke each year, of
which 692 000 are acute ischemic strokes (AISs).2
Treatment of AIS has undergone major developments during
the past 2 decades: ﬁrst, the cerebral computed tomography
made it possible to identify patients for medical thrombolysis;
second, the intravascular catheter-based revascularization of
cerebral vessels began to evolve. The modern intravascular
revascularization techniques are stent retriever thrombec-
tomy and direct aspiration of cerebral arterial clots.3–5
In addition to traditional causative factors, such as
hypertension, hypercholesterolemia, diabetes mellitus, smok-
ing, and obesity, bacterial inﬂammation has been suggested
to contribute directly or indirectly to the development of the
atherosclerosis and atherothrombotic events.6
Levels of CRP (C-reactive protein) seem to have correlation
with the incidence for cardiovascular events and stroke.7,8
CRP increases the adhesiveness of platelets for endothelium.9
Inﬂammation of atherosclerotic plaque may affect its growth
and contribute to plaque rupture, leading to thrombosis.10,11
Inﬂammation at nonvascular sites may also affect progression
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of atherosclerotic lesions via circulating chemical media-
tors.12 Severe periodontitis increased 2-fold the risk of
ischemic stroke among middle-aged men but not in women
after adjusting for age, sex, number of teeth, vascular risk
factors and diseases, childhood and adult socioeconomic
conditions, and lifestyle factors.13 In the Indian population,
periodontitis was even a stronger risk factor compared with
hypertension and smoking.14 According to recent studies,
periodontitis and tooth loss have an independent direct
association with stroke.15,16
We have earlier reported that bacterial DNA typical for
endodontic infection, mainly oral viridans streptococci,
was measured in 78.2% of thrombi, and periodontal
pathogens were measured in 34.7% of thrombus aspirates
from coronary arteries in patients with acute myocardial
infarction. The median value for the total amount of
bacterial DNA in coronary thrombus was 16 times higher
than that found in their blood samples.17 Furthermore, we
were able to detect these bacteria in ruptured and
nonruptured cerebral aneurysm samples18 and from
thrombus aspirates of patients with lower limb vascular
disorders.19 The presence of odontogenic bacteria, such
as Porphyromonas gingivalis and Streptococcus sanguinis,
has been shown in the atherosclerotic plaque of human
carotid artery histologically and by polymerase chain
reaction (PCR).20,21
In this study, we used a real-time quantitative PCR
(qPCR) to detect bacterial DNA from thrombi that have
been collected by stent retriever technique from the
cerebral arteries of patients with AIS. To our knowledge,
there are no earlier studies depicting the role of oral
bacteria in the thromboembolic events of cerebral arteries
among patients with AIS. We hypothesized that oral
bacterial DNA can be found in cerebral arterial thrombi
similarly as from coronary or inferior extremity peripheral
vessel thrombi.
Methods
The data that support the ﬁndings of this study are available
from the corresponding author on reasonable request.
The series comprises 75 patients with AIS who were treated
by intra-arterial thrombectomy between November 2013 and
January 2017 in the Acute Stroke Unit of Tampere University
Hospital, Tampere, Finland (Table). This series is a subset from
a larger Tampere BMG (Brain Microbes and Genetics) study,
focusing on the role of inﬂammation and genetics in ischemic
stroke. A neurologist (J.O.) examined all patients when they
arrived to the hospital and evaluated the possibility of
revascularization using thrombectomy together with a neuroin-
terventional radiologist (J.-P.P.). The cause of the brain large-
vessel occlusions of patients treated with endovascular
thrombectomy during the study period in Tampere University
Hospital was cardioembolic in 38% and atherosclerotic in 62%
of the patients (oral communication, 6th February, J.O.). The
only excluding criterion for recruiting patients was that if the
thrombus was not retrieved successfully using mechanical
thrombectomy. The median delay time between onset of an
Table. Patients’ Characteristics
Characteristics
Data for All Patients
(N=75)
Age, meanSD, y 66.912.4
Men, n (%) 52 (69.3)
Diabetes mellitus, n (%) 12 (16.0)
Dyslipidemia, n (%) 29 (38.7)
Arterial hypertension, n (%) 40 (53.3)
Coronary heart disease, n (%) 15 (20.0)
Cerebrovascular disease, n (%)* 20 (26.7)
Pulmonary disease, n (%) 4 (5.33)
Renal insufficiency, n (%) 7 (9.33)
Atrial fibrillation, n (%) 48 (64.0)
Heart failure, n (%) 10 (13.3)
Smoking status, %* 34.9
Location of thrombus aspirate, n (%)
ICA 25 (33.3)
MCA 72 (97.3)
ACA 6 (8.00)
PCA 1 (1.33)
VA 6 (8.00)
AB 1 (1.33)
Arrival time to the hospital
(quartile 1, median, quartile 2), h
1.20, 2.30, 3.80
AB indicates basilar artery; ACA, anterior cerebral artery; ICA, internal carotid artery;
MCA, middle cerebral artery; PCA, posterior cerebral artery; VA, vertebral artery.
*Smoking status was only available from 43 patients.
Clinical Perspective
What Is New?
• We found DNA of viridans streptococci in most aspired
thrombi of patients with acute ischemic stroke, which
suggests that oral bacteria may have a role in the cause of
cerebrovascular disease.
What Are the Clinical Implications?
• Repeated transient bacteremia, caused by poor dental care
or bacterial infections, may trap pathogens in atheroscle-
rotic plaques and promote rupture of the plaques; therefore,
regular dental care should be emphasized in the primary
prevention of acute ischemic stroke.
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ischemic stroke and hospital arrival was 2 hours 20 minutes
(range, 0-16 hours). Medical history was collected from the
Tampere University Hospital digital patient archives. Criteria for
dyslipidemia were fP-kol (cholesterol levels measured from
plasma after 12 hours fasting (f=fasting, P=plasma)) low-
density lipoprotein >3.0 mmol/L, fP-kol high-density lipopro-
tein <1.0 mmol/L, or fP triglycerides >2.0 mmol/L.
The study was approved by the ethics committee (R13093)
of the Tampere University Hospital. The study was explained
to the patients, and informed consent was obtained.
Mechanical Thrombectomy and Thrombus
Sample Collection
An introducer sheet was placed on a femoral artery, and a
control blood sample for bacterial genetic analysis was
collected through the sheet. A guiding catheter up to 9F
(Merci; Stryker Neurovascular) with a tip balloon was then
navigated into the carotid artery proximal to the occluded site.
The microcatheter (0.021 inches) with the guide wire was
used to navigate through the occluded site and to deploy the
stent retriever (Trevo; Stryker Neurovascular) over the
thrombus. An additional distal access catheter was used to
access the thrombus if needed. Forceful aspiration through
proximal catheters was acquired with a 60-mL syringe while
retrieving the deployed stent. In a minority of the cases, only
direct thrombus aspiration was used. Different device settings
were selected by operator case by case. Thrombectomy was
repeated until the angiologic result was satisfactory. The
gathered thrombus was divided into a 1.5-mL Eppendorf
microcentrifuge tube for qPCR analysis, and a histological
sample was placed in a formalin container.
Quantitative PCR
Bacterial DNA was extracted from samples using a commer-
cially available QIAamp DNA Mini Kit (Qiagen, Germany),
according to the instructions provided.
The presence of bacterial DNA in thrombus and blood
samples from the same patients was determined by using
published oligonucleotide primers and probes for Streptococ-
cus species (mainly the Streptococcus mitis group22), P
gingivalis, and Aggregatibacter actinomycetemcomitans23; and
universal bacterial primers and probe24 were determined with
RNaseP (Applied Biosystems, Foster City, CA), as a reference.
qPCR assays were performed using speciﬁc TaqMan allele
hybridization with the AbiPrism 7900 HT Sequence Detection
System (TaqMan; Applied Biosystems, Carlsbad, CA) under
standard conditions with the following cycle proﬁle: 50°C for
2 minutes, 95°C for 10 minutes, and 60 cycles of 95°C for
15 seconds and 58°C for 1 minutes. MasterMix was
prepared using Maxima Probe/ROX qPCR MasterMix
(Thermo Fischer Scientiﬁc, Waltham, MA), adding at ﬁnal
concentrations of 900 nmol/L of each primer and
250 nmol/L of each ﬂuorescence-labeled probe. All ampli-
ﬁcations and detections were performed as duplicates or
quadruples (in uncertain cases), depending on test runs in a
MicroAmp optical 384-well reaction plate with optical caps
(Sarsted, N€umbrecht, Germany) in a reaction volume of 5 lL,
with 1 lL of nondiluted DNA.
Human housekeeping gene, RNaseP, was used as a
reference measurement to determine the relative amount of
bacterial DNA in the sample. The determination was done by
the comparative threshold cycle (Ct) method. The critical Ct
is the cycle at which a statistically signiﬁcant increase in
ΔRn (normalized reporter) is ﬁrst detected and at which the
ﬂuorescence becomes detectable above background.
Ct is inversely proportional to the logarithm of the initial
number of template molecules (ie, the initial amount of
sample DNA). Calculation with the Ct method (DDCt,
DCtsampleDCtreference sample) was done with a simpliﬁca-
tion.25–28 First, the differences of the Ct values between
candidate bacteria and reference gene measurement (candi-
date bacteria–RNaseP [ΔCt]) for each sample were calcu-
lated; then, the comparative Ct (thrombus–patients own
blood [ΔΔCt]) was calculated. The samples were marked
bacterial positive, if 2DDCt≥2,29,30 or if there was ampliﬁed
bacterial DNA in the thrombus but not in the control sample.
DNA was extracted from the entire thrombus in most of the
cases. If the aspired thrombus was large, a small part of it
was taken and sent for histological analyses, and DNA was
extracted from the rest of the thrombus.
Statistical Analysis
Statistical analysis was done using IBM SPSS Statistics 25
(SPSS, Chicago, IL). Associations between the bacterial
ﬁndings and nominal parameters were analyzed using
Pearson’s v2 test. Age was treated as normally distributed
and, therefore, mean and sample SD values were calculated
and the Student t test was used. The Mann-Whitney U-test
was used to analyze the associations between bacterial
ﬁndings and the median arrival time to the hospital; these
values were not normally distributed. Statistical signiﬁcance
was set at P<0.05.
Results
Patient Characteristics
Of the study population, 69.3% (n=52) were men and 30.7%
(n=23) were women. The mean age of the patients was
66.9 years. None of the patients had been treated with
antibiotics or experienced severe infections or septicemia
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during the stroke. Characteristics of the study population are
presented in the Table.
Presence of Bacterial DNA in Thrombus Aspirates
Of the 75 patients who underwent thrombectomy for
treatment of acute stroke, 84.0% (n=63) of aspirated thrombi
were positive for bacterial DNA in qPCR compared with 16.0%
(n=12) of bacteria-negative thrombi. In addition, 78.7% (n=59)
of aspirated thrombi were positive for Streptococcus species,
mainly the S mitis group. Bacterial DNA of P gingivalis and A
actinomycetemcomitans was not found in thrombi. Of the
arterial blood samples that were collected during the
thrombectomy procedure, 9.33% (n=7) were positive for both
bacteria and Streptococcus species, mainly the S mitis group,
and 1.33% (n=1) were positive for both P gingivalis and A
actinomycetemcomitans.
The presence of Streptococcus species, mainly the S mitis
group DNA, was 5.10-fold inmedian and total bacteria DNAwas
7.93-fold in median, compared with the control blood sample
from the same patients. N-fold values for qPCR ﬁndings are
presented in Figure 1. Patients positive for any bacterial DNA
were more often men (P=0.067) and more often had diabetes
mellitus (P=0.074) and previous cerebrovascular disease
(P=0.046) compared with patients negative for any bacterial
DNA. However, there were no differences in patients’ demo-
graphic parameters between those positive or negative for the S
mitis group bacterial DNA (Figure 2).
Discussion
The present concept is that atherosclerosis is a complex
chronic inﬂammatory disorder driven by oxidized or otherwise
modiﬁed low-density lipoprotein.31–33 However, increasing
knowledge suggests that the atherosclerotic process may be
accelerated by bacterial infection.34,35
In our study, we found that thrombi collected from patients
with AIS were 84% positive for bacterial DNA and especially
for the S mitis group, whereas we could not detect DNA from
P gingivalis and A actinomycetemcomitans. To our knowledge,
this is the ﬁrst study in which bacterial signatures of the
thrombi of patients with AIS have been analyzed using qPCR.
Streptococcus species are mostly found in the oral cavity
of healthy individuals and in patients with periodontal
disease.36,37 The S mitis group comprises 20 species.38 Oral
bacteria can gain access to the bloodstream after trauma or
dental procedures (eg, root canal treatment or tooth extrac-
tion) and cause transient bacteremia. In tooth extraction,
most bacteria translocated into the circulation were viridans
streptococci.39 Viridans streptococci are the most common
cause of infective endocarditis and sepsis.40 It is possible that
oral bacteria can be trapped in atrial thrombosis in patients
with atrial ﬁbrillation. Moreover, it has been found that
bacteria can be found in the circulation without any clinical
symptoms.41
There are several ways how bacteria can enter the
atherosclerotic plaque. Bacteria can be phagocytosed and
end up in the atherosclerotic plaque via circulating macro-
phages. Bacteria can also directly drift in the bloodstream
through the vasa vasorum or the neovasculature vessels
developing inside the atherosclerotic plaque. Amoxicillin
medication in connection with tooth extraction decreased
the frequency of positive streptococci ﬁndings in peripheral
blood samples of the patients.42 A recent study conﬁrmed
that regular dental care lowers the risk for ischemic stroke.43
It has been shown that oral pathogens, such as viridans
group streptococci, can stimulate endothelial cells to produce
various proinﬂammatory cytokines, such as interleukin 6 and
interferon c.44,45 These cytokines are involved in the patho-
genetic pathway of atherosclerosis and may promote the
rupture of the plaque.46 Oral pathogens seem to activate toll-
like receptors, which mediate inﬂammation responses to
pathogens and cause endothelial dysfunction. Endothelial toll-
like receptors initiate inﬂammation and are an important
component in the establishment of plaque.47,48
In addition to the regular inﬂammatory pathway, bacteria
can straightforwardly interact with a platelet, causing its
activation.49 Bacterial surface proteins of S mitis can directly
bind to various platelet receptors.50,51 There can also be
indirect activation via plasma immunoglobulin G.52 Moreover,
odontogenic bacteria can secrete gingipains proteinase,
which can persuade an increase in platelet intracellular
[Ca2+] and lead to the activation and aggregation of
platelets.53,54 Activated platelets induce the recruitment
of proatherosclerotic cells and speed up the development of
Figure 1. N-fold values >2.0 are signiﬁcantly positive for
bacterial DNA. Line at the 2.0 y-axis level indicates that most
thrombi collected during thrombectomies of patients with acute
stroke are positive for bacterial DNA. Median N-fold values are
illustrated with black lines.
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atherothrombotic lesions.55 Activated platelets can take part
in the formation of cardioembolic stroke if the hemodynamic
conditions are altered, such as in atrial ﬁbrillation.56,57
One of the limitations of this study is its small sample
size, which prevents further subgroup analyses. The exact
impact of living bacteria on thrombosis cannot be declared
using PCR. In addition, the PCR method we used detects the
presence of bacterial DNA in the examined samples but is
unable to separate living bacteria from phagocytized bacte-
rial DNA. Culturing and staining are the most frequently
performed techniques when detecting bacterial species.
Nonetheless, the PCR method seems to be more accurate
and cost-effective in comparison with traditional cultur-
ing.58,59 Although our analysis revealed the absence of
P gingivalis and A actinomycetemcomitans in the thrombi, it
does not exclude the possibility of their role in the
pathogenesis of AIS. The presence of bacterial DNA was
deﬁned by an artiﬁcial cutoff value: the sample was
considered positive if it contained 2 times more bacterial
DNA compared with the control sample from the same
patient. In median, the samples contained 5 times more S
mitis DNA than the control samples. However, the validity is
also affected by the inhomogeneity of the thrombus
material.60,61
The ﬁndings of this study conﬁrm those of our previous
studies,17,19 suggesting that bacterial infection may be
involved in the pathogenesis of coronary and lower limb
thrombosis. However, it is not known whether the oral
bacteria are one of the causes of atherothrombotic events or
whether their role is solely as bystander. The exact role of
bacteria in AIS thus remains unclear.
Conclusion
We found DNA of Streptococcus species, mainly the S mitis
group, belonging to viridans streptococci, in most aspirated
thrombi of the patients with AIS. This suggests that viridans
streptococci may have a role in the cause of cerebrovascular
disease. Regular dental care should be emphasized in the
primary prevention of AIS.
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